维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Bleske BE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Carvedilol:therapeutic application and practiceguidelines显示文摘	Bleske BE Glibert EM Munger MA	1998	Pharmacotherapy1998，18，：	1
2	Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure显示文摘	Welage LS Kramer WG	1998	J Clin Pharmacol1998，38，8：	1
3	Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: relation to hemodynamic response显示文摘	NICKLAS JM MONSUR JC BLESKE BE	1999	Am J Cardiol1999，83，12：	1
4	Heart failure: clinical problem and management issues显示文摘	Nicklas JM Bleske BE Van Harrison R	2013	Prim Care2013，40，1：	1
5	Neutral effect on markers of heart failure,inflammation,endothelial activation and function,and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level显示文摘	Bleske BE Nicklas JM Bard RL	2006	J Am Coll Cardiol2006，47，2：	1
6	Clinical utility of azilsartan- chlorthalidone fixed combination in the management of hyperten- sion显示文摘	Shuster JE Bleske BE Dorseh MP	2012	Vasc Health Risk Manag2012，8，：	1
7	Effects of intravenous levosimendan on plasma neurohormone levels in patients with heart failure: relation to hemodynamic response显示文摘	Nicklas JM Monsur JC Bleske BE	1999	Am J Cardiol1999，83，1：	1
8	Food: an unrecognized source of loop diureticResistanee 显示文摘	Bard RL Bleske BE Nicklas JM	2004	Pharmacothcrapy2004，24，5：	1
9	Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and av- erage low-density lipoprotein level显示文摘	Bleske BE Nicklas JM Bard RL	2006	J Am Coil Cardiol2006，47，2：	1
10	Loading,pretreatment,and interindividual variability issues with clopidogrel dosing显示文摘	Bates ER Lau WC Bleske BE	2005	Circulation2005，111，20：	1
11	Acute effects of combination of IA and IB antiarrhythmias for the treatment of ventricular tachycardia显示文摘	Kluger J Fisher J	1989	Clin Pharmacol1989，29，7：	1
12	Pharmacokintics of torasemide in patients with decompensated and compensated congestive heart failure显示文摘	Blesks BE Welage LS Kramer WG	1998	J Clin Armacol1998，38，8：	1
13	Tone after high-dose HMG-CoA reductase inhibition in non diabetic patients with non- ischemic cardiomyopathy and a-erage low-density lipoprotein le-el显示文摘	Bleske BE Nicklas JM	2006	J Am Coll Cardiol2006，47，2：	1
14	Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity 显示文摘	Bleske BE Billi JE	1994	Resuscitation1994，28，3：	1
15	Clinical utility of azilsartan- chlorthalidone fixed combination in the management of hyper-tension显示文摘	Shuster JE Bleske BE Dorsch MP	2012	Vasc Health Risk Manag2012，8，：	1
16	Pharmacokinetics of torasemide in patients with decompensated and compensated congestive heart failure显示文摘	Bleske BE Welage LS Kramer WG	1998	J Clin Pharmacol1998，38，8：	1
17	The Effect of Continuous In-fusion Loop Diuretics in Patients With Acute Decompensated HeartFailure With Hypoalbuminemia 显示文摘	Bleske BE Clark MM Wu AH’	2013	J Cardiovasc Pharmacol Ther2013，18，4：	1
18	The Effect of Continuous In-fusion Loop Diuretics in Patients With Acute Decompensated HeartFailure With Hypoalbuminemia 显示文摘	Bleske BE Clark MM Wu AH’	2013	J Cardiovasc Pharmacol Ther2013，18，4：	1
19	The effect of sodium bicarbonate administration on th e vasopressor effect of high-dose eprnephrine during cardiopulmonary resuscitat ion in swine显示文摘	Rice TL	1993	Am J Emerg Med1993，11，5：	1
20	Team-based learning to improve learning outcomes in a therapeutics course sequence显示文摘	Bleske BE Remington TL Wells TD	2014	Am J Pharm Educ2014，78，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示